program details

C. Michael Gibson, MS, MD
Associate Professor of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA

1) Past Research Grants/Speakers Bureau
See attached

1) Eli Lilly & Co.
See attached

Peter R. Kowey, MD
System Division Chief
Main Line Arrhythmia & Cardiology Consultants
Cardiovascular Diseases, Lankenau Institute Medical Research
Wynnewood, PA  19096

1) Consultant
2) Advisory board member
3) Speaker’s bureau member

1) Astellas, sanofi-aventis, Solvay Pharm., Wyeth, Cardiome Pharma Corp.
2) Cardiome Pharma Corp
3) Cardiome Pharma Corp

Cecilia Linde, MD, PhD, FESC
Head of Cardilology
Department of Cardiology
Karolinska Hospital
171 76 Stockholm, Sweden

1) Consutant
2) Research Grants

1) Medtronic and St. Jude
2) Medtronic and the Sweden Heart and Lung Foundation

Peter Sleight , MD
Emeritus Professor of Cardiovascular Medicine
University of Oxford
Hon Consultant Physician
Oxford Radcliffe NHS Trust Level 5
John Radcliffe Hospital
Oxford OX3 9DU
United Kingdom

1) Speaker

1) GSK and Boehringer Ingelheim

Germano Di Sciascio, MD
Professor & Chairman of Cardiology
Director, Department of Cardiovascular Sciences
Campus Biomedico University of Rome
Via Alvaro del Portillo 200
00128 Rome, Italy

None

None

Stephen D. Wiviott, MD
Associate Physician
Bringham and Women's Hospital
Wellesly, MA

1) Consultant
2) Advisory board
3) Speaker's bureau member and writing
4) Research grants
5) CME providers
6) Through the TIMI Study Group  

3) Daiichi Sankyo Co. Ltd
4) Daiichi Sankyo Co. Ltd and Eli Lilly & Co.
6) Eli Lilly & Co.
See attached

Partirck A. Gladding, MD
Cardiology Research Fellow
Green Lane Cardiovascular Department
Auckland City Hospital
Auckland 1005, New Zealand

1) Support

1) GLREF, NHF, sanofi NZ

Christian W. Hamm, MD, FESC, FACC
Director Cardiology
Kerchkoff-Klinik GmbH
Benekestr. 2-8
61231 Bad Nauheim, Germany

1) Speaker Honorarium
2) Consultant

1) Merck, GSK, Lilly, The Medicines Company, sanofi-aventis, Medtronic, Cordis, Braun, CVT, Abbott, Roche
2) GSK, The Medicines Company, snaofi-aventis